1969. SARS-CoV-2 seroprevalence among patients with cancer and healthcare workers from an oncology referral center during the first year of COVID-19 vaccination in Mexico

BACKGROUND: Cancer patients (CPs) with COVID-19 have an increased risk of adverse outcomes. In addition, CPs seem to have a lower immune response to SARS-CoV-2 vaccination. This study aimed to evaluate SARS-CoV-2 spike antibodies (anti-S Abs) following COVID-19 vaccination in CPs and healthcare work...

Descripción completa

Detalles Bibliográficos
Autores principales: Villaseñor-Echavarri, Rodrigo, De-la-Rosa-Martinez, Daniel, Frias-Jimenez, Emmanuel, Martin-Onraet, Alexandra, Ruiz-Garcia, Erika, Cruz-Cruz, Alonso, Herrera-Montalvo, Luis Alonso, Vilar-Compte, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752446/
http://dx.doi.org/10.1093/ofid/ofac492.1594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752446/
http://dx.doi.org/10.1093/ofid/ofac492.1594

Ejemplares similares